Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
203.00    0.40 (0.20%)
Bid:
202.40
Ask:
203.40
Spread: 1.00 (0.494%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

16 Jul 2009 07:00

RNS Number : 7555V
Ashmore Group PLC
16 July 2009
 



 Ashmore Group plc

+0700 16 July 2009 

TRADING UPDATE AND ASSETS UNDER MANAGEMENT sTATEMENT

Ashmore Group plc ("Ashmore", the "Group"), a leading specialist emerging markets asset manager, announces the following trading update and Assets under Management ("AuM") statement in respect of the period ended 30 June 2009.

Assets under Management

Actual 

Estimated 

Estimated

Theme

31 March

2009

(US$ billion)

30 June

2009

(US$ billion)

Movement

Q3vsQ4

(%)

External Debt 

14.4

16.0

+11%

Local Currency

4.6

4.5

-2%

Special Situations

4.4

4.3

-2%

Equity

0.1

0.1

-

Total

23.5

24.9

+6%

The final quarter of the financial year ended 30 June 2009 saw AuM increase by US$1.4 billion (6%) to US$24.9 billion. This increase comprises investment performance of US$1.9 billion, arising in external debt and local currency, partially offset by net redemptions of US$0.5 billion, solely within the local 

currency theme.

During the financial year ended 30 June 2009, AuM decreased to US$24.9 billion from US$37.5 billion. Investment performance was US$5.1 billion adverseUS$7.1 billion adverse in the first half, and US$2.0 billion positive in the second half. Neredemptions in the period were US$7.4 billion, of which US$5.7 billion arose in the first half of the year across all themes, largely reflecting the liquidity needs of our clients in the extreme market conditions. Over the second half, redemptions have slowed significantly, while subscription levels have begun to increase within both public funds and segregated mandates, with net subscriptions achieved in May and June.  

The expansion of the average revenue margin experienced in the first half, principally because of the AuM mix, has been impacted by the timing and make up of external debt and local currency redemptions at the back end of the first half, and through the second half. This has resulted in the average revenue margin for the final quarter returning to the FY07/08 level of 103bps.  

The results for the full year ended 30 June 2009 are in-line with management expectations in the current operating environment. The loss for the year in respect of FX hedge contracts is £42.8 million (6 months to 31 December 2008: £54.2 million)of which £4.5 million (6 months to 31 December 2008: £12.7 million) relates to the mark-to-market of forward contracts to partially hedge FY09/10 management fees. These FY09/10 forward contracts have an aggregate notional value 

of US$120 million, marked at the year end rate of GBP1:1.6458USD. Any future gains or losses on these contracts will arise from deviations from this year end rate.

The Group will announce its results in respect of the financial year to 30 June 2009 on 

15 September 2009. There will be a presentation for analysts at 0900 on that date at the offices of Goldman Sachs at Peterborough Court133 Fleet Street London EC4A 2BB. A copy of the presentation will be made available on the Group's website at www.ashmoregroup.com.

For further information, please contact:

Ashmore Group plc

Graeme Dell, Group Finance Director +44 (0)20 3077 6000

Penrose Financial  +44(0)20 7786 4888 

Gay Collins +44(0)7798 626282

Ashmore@penrose.co.uk 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTIFFVLDEIELIA
Date   Source Headline
8th Nov 20224:20 pmRNSHolding(s) in Company
28th Oct 202210:13 amRNSHolding(s) in Company
14th Oct 20222:11 pmRNSResult of AGM
14th Oct 20227:00 amRNSTrading Statement
5th Oct 20226:03 pmRNSHolding(s) in Company
23rd Sep 20224:56 pmRNSDirector/PDMR Shareholding
15th Sep 202210:36 amRNSDirector/PDMR Shareholding
14th Sep 20226:00 pmRNSHolding(s) in Company
9th Sep 20225:19 pmRNSNotice of AGM
2nd Sep 20227:00 amRNSFinal Results
22nd Jul 202211:33 amRNSDirectorate Change
14th Jul 20227:00 amRNSTrading Statement
25th Apr 20227:00 amRNSHolding(s) in Company
14th Apr 20227:00 amRNSTrading Statement
1st Apr 20223:02 pmRNSDirector/PDMR Shareholding
21st Mar 20224:30 pmRNSDirectorate Change
17th Mar 202211:35 amRNSDirector/PDMR Shareholding
17th Jan 20227:00 amRNSTrading Statement
13th Dec 202111:34 amRNSDirector/PDMR Shareholding
15th Oct 20213:42 pmRNSResult of AGM
14th Oct 20217:00 amRNSTrading Statement
23rd Sep 202112:27 pmRNSDirector/PDMR Shareholding
23rd Sep 202112:24 pmRNSDirector/PDMR Shareholding
17th Sep 20219:52 amRNSDirector/PDMR Shareholding
17th Sep 20219:48 amRNSDirector/PDMR Shareholding
10th Sep 20214:00 pmRNSNotice of AGM
3rd Sep 20217:00 amRNSFinal Results
14th Jul 20217:00 amRNSTrading Statement
30th Apr 20212:51 pmRNSDirector/PDMR Shareholding
23rd Apr 20213:12 pmRNSDirectorate Change
16th Apr 20217:00 amRNSTrading Statement
13th Apr 20213:45 pmRNSAGM voting result update statement
6th Apr 20212:54 pmRNSDirector/PDMR Shareholding
6th Apr 20212:37 pmRNSDirector/PDMR Shareholding
18th Mar 20216:02 pmRNSDirector/PDMR Shareholding
16th Feb 20214:35 pmRNSHolding(s) in Company
16th Feb 20214:29 pmRNSDirector/PDMR Shareholding
10th Feb 20217:00 amRNSHalf-year Report
15th Jan 20217:00 amRNSTrading Statement
11th Dec 20205:40 pmRNSDirector/PDMR Shareholding
11th Dec 20205:37 pmRNSDirector/PDMR Shareholding
19th Oct 20206:20 pmRNSHolding(s) in Company
19th Oct 20205:47 pmRNSDirector/PDMR Shareholding
16th Oct 20204:14 pmRNSResult of AGM
14th Oct 20207:00 amRNSTrading Statement
7th Oct 20209:42 amRNSHolding(s) in Company
25th Sep 20202:20 pmRNSAGM arrangements
22nd Sep 20206:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20206:03 pmRNSDirector/PDMR Shareholding
22nd Sep 20208:26 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.